Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872675PMC
http://dx.doi.org/10.1155/2018/6872748DOI Listing

Publication Analysis

Top Keywords

aortic valve
12
cardiogenic shock
12
valve-in-valve transcatheter
8
transcatheter aortic
8
valve implantation
8
stentless bioprosthetic
8
bioprosthetic aortic
8
aortic insufficiency
8
valve degeneration
8
valve-in-valve tavi
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!